Skip to main content

Corporate insider profile

Neil Kumar Insider Trades

Latest reported as Chief Executive Officer of BridgeBio Pharma, Inc. (BBIO).

Purchase filings
0
Reported companies
1
Net open-market value
-$17,036,146.55
Latest transaction
Sep 17, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Sep 17, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale10,000$69.08$690,847
Aug 19, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale44,980$82.86$3,727,250
Jun 5, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale80,000$67.67$5,413,288
May 21, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale26,103$69.44$1,812,522
May 8, 2026BridgeBio Pharma, Inc. (BBIO)Chief Executive OfficerSale80,000$67.40$5,392,240